Yeda Research and Development

Shay Shemesh is a seasoned finance executive with over two decades of leadership in biotech, medtech, and high-tech. As CFO at Yeda, he directs financial strategy and operations, ensuring fiscal health while supporting the commercialization of Weizmann Institute innovations. He previously served as CFO at Nucleix, a non-invasive cancer diagnostics company; CFO and Director of Operations at MultiPhy, an optical communication semiconductor leader; and CFO at BioView, a publicly traded biotech firm. Shay holds an MBA in Finance and brings expertise in corporate finance, strategic planning, fundraising, and operations to advance Yeda’s goals.